<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04349670</url>
  </required_header>
  <id_info>
    <org_study_id>GPOEM</org_study_id>
    <nct_id>NCT04349670</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of GPOEM in the Treatment of Gastroparesis</brief_title>
  <official_title>Safety and Efficacy of GPOEM in the Treatment of Gastroparesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS San Raffaele</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS San Raffaele</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the clinical efficacy and safety in the treatment of
      gastroparesis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After being informed about the data collected, all the patients affected with gastroparesis
      undergoing Gastric Per-Oral Endoscopic Myotomy (GPOEM) will be included in the observational
      protocol.

      Data concerning pre-operative symptoms and results of the imaging studies will be recorded
      together with operative time and operative complications.

      Patients will undergo periodical clinical consults and gastric emptying scintigraphy to
      assess the improvement in the symptoms and gastric motility.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2020</start_date>
  <completion_date type="Anticipated">April 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical efficacy</measure>
    <time_frame>1, 3, 6, 12, 24 months</time_frame>
    <description>Change in symptomatological scores</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Functional efficacy</measure>
    <time_frame>3, 12, 24 months</time_frame>
    <description>Change of scintigraphy evaluated gastric emptying time</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Complications</measure>
    <time_frame>peri-operative time (48 hours)</time_frame>
    <description>Evaluation of the operative adverse events</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation of symptoms</measure>
    <time_frame>3, 12, 24 months</time_frame>
    <description>Evaluate the correlation between symptoms and gastric emptying</description>
  </secondary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Gastroparesis</condition>
  <condition>Gastroparesis Postoperative</condition>
  <condition>Gastroparesis With Diabetes Mellitus</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>GPOEM - gastric per-oral endoscopic myotomy</intervention_name>
    <description>Endoscopic section of the pyloric muscle with submucosal tunnel technique.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients affected with clinical or scintigrafic severe gastroparesis or patients with
        moderate symptoms/gastric scintigraphic delayed emptying with good response to botulinum.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Gastroparesis (GCSI &gt; 2 OR Gastric emptying half-time &gt; 180 min OR gastric retention
             at 120 min &gt; 60% OR good response to botulinum if former criteria not met)

        Exclusion Criteria:

          -  Age &lt; 18 years

          -  Inability to understand protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Pier Alberto Testoni</name>
      <address>
        <city>Milan</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>April 15, 2020</study_first_submitted>
  <study_first_submitted_qc>April 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 16, 2020</study_first_posted>
  <last_update_submitted>May 27, 2020</last_update_submitted>
  <last_update_submitted_qc>May 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IRCCS San Raffaele</investigator_affiliation>
    <investigator_full_name>Pier Alberto Testoni</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>GPOEM</keyword>
  <keyword>gastroparesis</keyword>
  <keyword>pyloromyotomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroparesis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

